361 related articles for article (PubMed ID: 30841430)
21. Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats.
Zabad IEM; Amin MN; El-Shishtawy MM
Life Sci; 2019 Dec; 239():117088. PubMed ID: 31759039
[TBL] [Abstract][Full Text] [Related]
22. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
[TBL] [Abstract][Full Text] [Related]
23. Astaxanthin Promotes Nrf2/ARE Signaling to Alleviate Renal Fibronectin and Collagen IV Accumulation in Diabetic Rats.
Zhu X; Chen Y; Chen Q; Yang H; Xie X
J Diabetes Res; 2018; 2018():6730315. PubMed ID: 29744366
[TBL] [Abstract][Full Text] [Related]
24. Renoprotective effect of calycosin in high fat diet-fed/STZ injected rats: Effect on IL-33/ST2 signaling, oxidative stress and fibrosis suppression.
Elsherbiny NM; Said E; Atef H; Zaitone SA
Chem Biol Interact; 2020 Jan; 315():108897. PubMed ID: 31726037
[TBL] [Abstract][Full Text] [Related]
25. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L
J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441
[TBL] [Abstract][Full Text] [Related]
26. Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy.
Qiu YY; Tang LQ; Wei W
Mol Cell Endocrinol; 2017 Mar; 443():89-105. PubMed ID: 28087385
[TBL] [Abstract][Full Text] [Related]
27. Astaxanthin Promotes Nrf2/ARE Signaling to Inhibit HG-Induced Renal Fibrosis in GMCs.
Xie X; Chen Q; Tao J
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29621130
[TBL] [Abstract][Full Text] [Related]
28. Moringa oleifera impedes protein glycation and exerts reno-protective effects in streptozotocin-induced diabetic rats.
Ahmad S; Pandey AR; Rai AK; Singh SP; Kumar P; Singh S; Gulzar F; Ahmad I; Sashidhara KV; Tamrakar AK
J Ethnopharmacol; 2023 Apr; 305():116117. PubMed ID: 36584917
[TBL] [Abstract][Full Text] [Related]
29. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of glyoxalase 1, a polyfunctional defense enzyme, by quercetin in the brain in streptozotocin-induced diabetic rats.
Zhu X; Cheng YQ; Lu Q; Du L; Yin XX; Liu YW
Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1237-1245. PubMed ID: 30062553
[TBL] [Abstract][Full Text] [Related]
31. Apigenin-Loaded Solid Lipid Nanoparticle Attenuates Diabetic Nephropathy Induced by Streptozotocin Nicotinamide Through Nrf2/HO-1/NF-kB Signalling Pathway.
Li P; Bukhari SNA; Khan T; Chitti R; Bevoor DB; Hiremath AR; SreeHarsha N; Singh Y; Gubbiyappa KS
Int J Nanomedicine; 2020; 15():9115-9124. PubMed ID: 33244230
[TBL] [Abstract][Full Text] [Related]
32. Notoginsenoside R1 Protects db/db Mice against Diabetic Nephropathy via Upregulation of Nrf2-Mediated HO-1 Expression.
Zhang B; Zhang X; Zhang C; Shen Q; Sun G; Sun X
Molecules; 2019 Jan; 24(2):. PubMed ID: 30634720
[TBL] [Abstract][Full Text] [Related]
33. The crosstalk between Sirt1 and Keap1/Nrf2/ARE anti-oxidative pathway forms a positive feedback loop to inhibit FN and TGF-β1 expressions in rat glomerular mesangial cells.
Huang K; Gao X; Wei W
Exp Cell Res; 2017 Dec; 361(1):63-72. PubMed ID: 28986066
[TBL] [Abstract][Full Text] [Related]
34. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of glomerular injury in diabetic mice with tert-butylhydroquinone through nuclear factor erythroid 2-related factor 2-dependent antioxidant gene activation.
Li H; Zhang L; Wang F; Shi Y; Ren Y; Liu Q; Cao Y; Duan H
Am J Nephrol; 2011; 33(4):289-97. PubMed ID: 21389693
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the TGFβ1- ILK-Akt signaling pathway in the effects of hesperidin in type 2 diabetic nephropathy.
Zhang Y; Wang B; Guo F; Li Z; Qin G
Biomed Pharmacother; 2018 Sep; 105():766-772. PubMed ID: 29909344
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.
Zhang Y; Tao C; Xuan C; Jiang J; Cao W
Oxid Med Cell Longev; 2020; 2020():9542165. PubMed ID: 32855769
[TBL] [Abstract][Full Text] [Related]
38. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
[TBL] [Abstract][Full Text] [Related]
39. Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.
Antar SA; Abdo W; Taha RS; Farage AE; El-Moselhy LE; Amer ME; Abdel Monsef AS; Abdel Hamid AM; Kamel EM; Ahmeda AF; Mahmoud AM
Life Sci; 2022 Feb; 291():120260. PubMed ID: 34968466
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
